Calendar TOT BIOPHARM International Company Limited

Equities

1875

HK0000545266

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
1.55 HKD +1.97% Intraday chart for TOT BIOPHARM International Company Limited -5.49% -21.32%

Chart calendar TOT BIOPHARM International Company Limited

832d37eb29869a9f8ee74d4967195d9.3iGwY9lvntLN5t652sQeWzZc1v2AoxEQK_k_DtRbbwA.m0PFVaMu_Iqroe7Y65xtNE8Ekb-0zGFEWLtta5cQV0WcGMohkQvMlZuJ5g~a75fd9ae2fc6efe30dfb21c393e64db9

Upcoming events on TOT BIOPHARM International Company Limited

2024-08-08 Q2 2024 Earnings Release (Projected)
2025-03-24 Q4 2024 Earnings Release (Projected)
2025-08-07 Q2 2025 Earnings Release (Projected)
2026-03-23 Q4 2025 Earnings Release (Projected)

Past events on TOT BIOPHARM International Company Limited

2024-03-14 Q4 2023 Earnings Release
2023-08-10 Q2 2023 Earnings Release
2023-06-26 10:00 pm Annual General Meeting
2023-03-22 Q4 2022 Earnings Release
2022-08-11 Interim 2022 Earnings Release
2022-03-23 FY 2021 Earnings Release
2021-08-11 Interim 2021 Earnings Release
2021-06-24 11:00 pm Annual General Meeting
2021-03-22 FY 2020 Earnings Release
2020-08-12 Interim 2020 Earnings Release
2020-03-16 FY 2019 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022
Net sales
Million CNY
Released
Forecast
Spread
45,3
58,0
-21.88%
22,5
53,2
-57.73%
76,3
51,9
47.06%
0,00


EBITDA
Million CNY
Released
Forecast
Spread
-242
-401
39.59%
-257
-215
-19.4%
-225
-202
-11.67%
0,00


EBIT
Million CNY
Released
Forecast
Spread
-270
-417
35.35%
-289
-234
-23.22%
-260
-235
-10.7%
0,00


Earnings before Tax (EBT)
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


Net income
Million CNY
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-49,9


EPS
CNY
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-0,08


Announcement Date17/03/2023/03/2124/03/2223/03/23

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1875 Stock
  4. Calendar TOT BIOPHARM International Company Limited